Semaglutide for Sale — Research-Grade, ADS-tested
Looking to buy Semaglutide? MyGLP1Store offers Semaglutide (SEMA) for sale as a third-party lab-tested research peptide with a published Analytical Data Sheet (ADS), documented >99% purity, free bacteriostatic water, and same-day U.S. shipping. Veteran-owned and trusted by researchers (Trustpilot 4.8). For laboratory research use only.
SEMA — Semaglutide (Lyophilized Research Peptide, 5mg–15mg)
SEMA (Semaglutide) is a GLP-1 receptor agonist peptide widely studied in metabolic and endocrinology research. It is primarily investigated for its role in glucose-dependent insulin secretion, appetite signaling pathways, and energy balance regulation.
In research models, Semaglutide is commonly explored for its effects on satiety mechanisms, glycemic control pathways, and metabolic efficiency.
Semaglutide Specifications
| Peptide | Semaglutide (SEMA) |
| CAS Number | 910463-68-2 |
| Receptor Class | GLP-1 receptor agonist (single agonist) |
| Purity | >99% (third-party ADS-verified) |
| Form | Lyophilized powder |
| Vial Sizes | 5mg, 10mg, 15mg |
| Storage | Store at -20°C; after reconstitution, refrigerate at 2–8°C and use within 30 days |
Potential Research Applications:
- GLP-1 receptor pathway studies
- Glucose metabolism and insulin response research
- Appetite regulation and satiety signaling models
- Energy balance and metabolic function investigations
- Combination research with amylin analogs (e.g., CagriSema)
How Semaglutide Compares to Other GLP-1 Research Peptides
Semaglutide is a single GLP-1 receptor agonist — the baseline compound of the incretin research class — compared with tirzepatide (GLP-1/GIP dual agonist) and retatrutide (GLP-1/GIP/glucagon triple agonist).
| Compound | Receptor Targets | Research Class |
|---|---|---|
| Semaglutide (SEMA) | GLP-1 | Single agonist |
| Tirzepatide (TIRZ) | GLP-1 + GIP | Dual agonist |
| Retatrutide (RETA) | GLP-1 + GIP + Glucagon | Triple agonist |
Selected Research Literature
- Wilding JPH, et al. — STEP 1: once-weekly semaglutide in adults with overweight or obesity. [PubMed]
- Lau J, et al. — discovery of the once-weekly GLP-1 analog semaglutide: molecular design and receptor pharmacology. [PubMed]
- Enebo LB, et al. — concomitant cagrilintide and semaglutide for combination-pathway research (CagriSema). [PubMed]
Semaglutide (SEMA) — Frequently Asked Questions
Where can I buy the semaglutide research peptide?
You can buy semaglutide directly from MyGLP1Store in 5mg, 10mg, and 15mg lyophilized research vials. Every batch is third-party ADS-tested, ships same-day from the US, and includes free bacteriostatic water. For laboratory research use only.
Is SEMA the same as semaglutide?
Yes. SEMA is the research shorthand for semaglutide, a GLP-1 receptor agonist peptide studied in metabolic research models.
Is your semaglutide third-party tested?
Yes — every batch is third-party lab tested with a published Analytical Data Sheet (ADS) and documented >99% purity.
How should semaglutide be stored?
Store lyophilized vials at -20°C. After reconstitution with bacteriostatic water, refrigerate at 2–8°C and use within 30 days.
What is CagriSema?
CagriSema is the studied combination of semaglutide with the amylin analog cagrilintide. We supply it as a Cagrilintide + Semaglutide blend for combination-pathway research.
For laboratory and research use only. Not for human or veterinary consumption. Nothing on this page is medical advice or a dosing recommendation.
Related Research Compounds
Semaglutide (SEMA) is frequently studied alongside other GLP-1 and metabolic research peptides. Explore related ADS-tested lyophilized compounds:
- Tirzepatide (TIRZ) — dual GIP/GLP-1 receptor agonist research peptide.
- Buy Retatrutide (RETA) — triple GIP/GLP-1/glucagon receptor agonist.
- Cagrilintide peptide (CAGRI) — long-acting amylin analog research compound.
- Cagrilintide + Semaglutide blend — dual-peptide metabolic research combination.
Semaglutide — Further Research Reading
Background methodology and comparative data from our research library:
- Semaglutide research guide — GLP-1 receptor mechanism and published trial data.
- Semaglutide vs tirzepatide — head-to-head dose comparison and outcomes.
- GLP-1 research peptides — how the receptor class is studied across compounds.
- How to reconstitute GLP-1 peptides — step-by-step method and concentration maths.
- Quality standards in GLP-1 research — how laboratories evaluate purity and documentation.
- Cagrilintide + Semaglutide blend — the CagriSema combination studied alongside semaglutide alone.
- About our research lead — who reviews the analytical data behind every lot.





Reviews
There are no reviews yet.